Effects of acute phase intensive electrical muscle stimulation in COVID-19 patients requiring invasive mechanical ventilation: an observational case-control study

Yohei Tsuchikawa,Shinya Tanaka,Daisuke Kasugai,Riko Nakagawa,Miho Shimizu,Takayuki Inoue,Motoki Nagaya,Takafumi Nasu,Norihito Omote,Michiko Higashi,Takanori Yamamoto,Naruhiro Jingushi,Atsushi Numaguchi,Yoshihiro Nishida

DOI: https://doi.org/10.1038/s41598-024-55969-8

IF: 4.6

2024-03-04

Scientific Reports

Abstract:We investigated the effects of acute-phase intensive electrical muscle stimulation (EMS) on physical function in COVID-19 patients with respiratory failure requiring invasive mechanical ventilation (IMV) in the intensive care unit (ICU). Consecutive COVID-19 patients requiring IMV admitted to a university hospital ICU between January and April 2022 (EMS therapy group) or between March and September 2021 (age-matched historical control group) were included in this retrospective observational case–control study. EMS was applied to both upper and lower limb muscles for up to 2 weeks in the EMS therapy group. The study population consisted of 16 patients undergoing EMS therapy and 16 age-matched historical controls (median age, 71 years; 81.2% male). The mean period until initiation of EMS therapy after ICU admission was 3.2 ± 1.4 days. The EMS therapy group completed a mean of 6.2 ± 3.7 EMS sessions, and no adverse events occurred. There were no significant differences between the two groups in Medical Research Council sum score (51 vs. 53 points, respectively; P = 0.439) or ICU mobility scale at ICU discharge. Addition of upper and lower limb muscle EMS therapy to an early rehabilitation program did not result in improved physical function at ICU discharge in severe COVID-19 patients.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether acute - phase intensive electrical muscle stimulation (EMS) can improve the physical function of COVID - 19 patients requiring invasive mechanical ventilation (IMV) in the intensive care unit (ICU). Specifically, the researchers wanted to evaluate whether adding EMS treatment to the upper and lower limb muscles in the early rehabilitation program, compared with only early rehabilitation, could increase the muscle strength of patients and improve their physical function and clinical outcomes at the time of ICU discharge.

The research background indicates that severe COVID - 19 patients usually require long - term mechanical ventilation support, which can lead to ICU - acquired weakness, manifested as problems such as decreased muscle strength and limited mobility. Although early exercise and rehabilitation training are beneficial for severe COVID - 19 patients, due to limitations in medical resources, this active early rehabilitation is often difficult to implement. Therefore, the researchers explored EMS as a method of inducing muscle contractions that does not require active patient participation and is safe, in order to prevent early damage and enhance the functional recovery of these patients.

However, according to the research results of the paper, although EMS treatment has been proven to be safe in the ICU setting, as part of the standard early rehabilitation program, it has not significantly improved the muscle strength of patients or their physical function and clinical outcomes at discharge. This indicates that in severe COVID - 19 patients, EMS may not be an effective additional treatment method to improve their muscle strength and physical function. The study also pointed out the directions for future research, including determining the optimal frequency and duration of EMS, and more appropriate physical assessment methods to improve the clinical outcomes of these patients.